2Konstantinides S, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmona- ryembolism[J].Eur Heart J,2014V35N43:3033-3069,3069 a-k.
3Jaff M R,McMurtry M S,Archer S L,etal. Management of massive and submassive pulmonary embolism,iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary by-pertension:a scientific statement from the American Heart As sociation[J]. Circulation,2011,123: 1788 -1830.
7Guyatt G H, Akl E A, Crowther M, et al. Antithrornbotictherapy and prevention of thrombosis, 9th ed= American Col- lege of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest,2012,141(2)(Suppl) :7S- 47S.
5Yalamanchili K, Fleisher AG, Lehrman SG, et al. Open pulmonary embolectomy for treatnlent of major pulmonary embolism. Ann Thorae Surg, 2004,77:819-823.
6Hann CL, Streiff MB. The role of vena caval filters in the management of venous thromboembolism. Blood Rev, 2005, 19 : 179-202.
7PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d' Embolie Pulmonaire par Interruption Cave) randomized study. Circulation, 2005,112:416-422.
8Karmy-Jones R, Jurkovich GJ, Velmahos GC, et al. Practice patterns and outcomes of retrievable vena cava filters in trauma patients : an AAST multicenter study. J Trauma, 2007,62 : 17-24.
9Barral FG. Vena cava filters: why, when, what and how? J Cardiovasc Surg (Torino) , 2008,49:35-49.
10Meyer G, Sors H, Charbonnier B, et al. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism : a European nmlticenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism. J Am Coll Cardiol, 1992, 19:239-245.
